Trials / Unknown
UnknownNCT04498091
EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The COVID-19 pandemic highlights the importance of the prognosis of co-morbidities, such as coronary artery disease, which significantly increase the risk of mortality in patients infected with SARS-CoV2. Investigators have recently studied the complex links between respiratory infections, particularly pneumonia, and type 2 myocardial infarction (MI) in many respects. The etiology of type 2 MI is based on an imbalance of myocardial oxygen supply/need in the absence of rupture/erosion of atheromatous plaques. Based on the RICO survey data, the investigators investigated whether COVID-19-related sepsis and/or respiratory failure could be an underlying mechanism of MI2.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Biological data | Biological data |
| OTHER | Clinical data | Clinical data |
Timeline
- Start date
- 2020-03-15
- Primary completion
- 2020-07-01
- Completion
- 2021-07-01
- First posted
- 2020-08-04
- Last updated
- 2020-08-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04498091. Inclusion in this directory is not an endorsement.